These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24975380)

  • 21. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia.
    Kazancioglu S; Bastug A; Kayaaslan B; Mutlu NM; Calci E; Turhan T; Mumcuoglu I; Akinci E; Bodur H
    J Infect Dev Ctries; 2022 Feb; 16(2):362-368. PubMed ID: 35298433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
    Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
    Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
    Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
    J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid.
    Forster J; Hoenigl M; Suerbaum S; Wagener J; Dichtl K
    Mycoses; 2022 Jul; 65(7):709-714. PubMed ID: 35506957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
    Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
    Prüller F; Wagner J; Raggam RB; Hoenigl M; Kessler HH; Truschnig-Wilders M; Krause R
    Med Mycol; 2014 Jul; 52(5):455-61. PubMed ID: 24906361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
    Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
    Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-(1→3)-D-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study.
    Erb T; Mihai S; Strauß R; Herbst L; Castellanos I; Diesch K; Cipa F; Bihlmaier K; Lang A-K; Ganslmayer M; Willam C; Bremer F; Fürst J; Beyer C; Bogdan C; Rath A; Held J
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0072523. PubMed ID: 37823695
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
    Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
    Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
    Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
    Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil.
    Giacobbe DR; Esteves P; Bruzzi P; Mikulska M; Furfaro E; Mesini A; Tatarelli P; Grignolo S; Viscoli C; Colombo AL; Del Bono V
    Clin Microbiol Infect; 2015 Oct; 21(10):954.e9-17. PubMed ID: 26070961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit.
    Gill CM; Kenney RM; Hencken L; Mlynarek ME; Alangaden GJ; Samuel LP; Davis SL
    Diagn Microbiol Infect Dis; 2019 Oct; 95(2):162-165. PubMed ID: 31248660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults With Candidemia: A 5-year Experience in a Tertiary Hospital.
    Agnelli C; Bouza E; Del Carmen Martínez-Jiménez M; Navarro R; Valerio M; Machado M; Guinea J; Sánchez-Carrillo C; Alonso R; Muñoz P
    Clin Infect Dis; 2020 Apr; 70(9):1925-1932. PubMed ID: 31680136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults.
    Troughton JA; Browne G; McAuley DF; Walker MJ; Patterson CC; McMullan R
    J Infect; 2010 Nov; 61(5):403-9. PubMed ID: 20849877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study.
    Muñoz P; Vena A; Machado M; Martínez-Jiménez MC; Gioia F; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
    J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv13-iv19. PubMed ID: 29608752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
    Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
    Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.
    Prattes J; Hoenigl M; Rabensteiner J; Raggam RB; Prueller F; Zollner-Schwetz I; Valentin T; Hönigl K; Fruhwald S; Krause R
    Mycoses; 2014 Nov; 57(11):679-86. PubMed ID: 25040144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of Candida mannan antigen and anti-mannan IgG and IgM antibodies for Candida infection.
    Wang K; Luo Y; Zhang W; Xie S; Yan P; Liu Y; Li Y; Ma X; Xiao K; Fu H; Cai J; Xie L
    Mycoses; 2020 Feb; 63(2):181-188. PubMed ID: 31755600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.